We conducted an in‐depth analysis of components, regulators, and activation products encompassing the classical, alternative, and terminal pathways of complement in adults with DS versus euploid controls; further, we examined whether dementia or APOE ε4 genotype affected complement protein levels in DS. The gene discussed is APOE; the disease is Dravet syndrome.